[go: up one dir, main page]

NO20015380D0 - Tio-oxindole derivative - Google Patents

Tio-oxindole derivative

Info

Publication number
NO20015380D0
NO20015380D0 NO20015380A NO20015380A NO20015380D0 NO 20015380 D0 NO20015380 D0 NO 20015380D0 NO 20015380 A NO20015380 A NO 20015380A NO 20015380 A NO20015380 A NO 20015380A NO 20015380 D0 NO20015380 D0 NO 20015380D0
Authority
NO
Norway
Prior art keywords
tio
oxindole derivative
oxindole
derivative
Prior art date
Application number
NO20015380A
Other languages
Norwegian (no)
Other versions
NO320912B1 (en
NO20015380L (en
Inventor
Andrew Fensome
Puwen Zhang
Marci C Koko
Lin Zhi
Todd K Jones
Christopher M Tegley
Edward G Melenski
James P Edwards
Jay E Wrobel
Original Assignee
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,033 external-priority patent/US6355648B1/en
Application filed by Ligand Pharm Inc filed Critical Ligand Pharm Inc
Publication of NO20015380D0 publication Critical patent/NO20015380D0/en
Publication of NO20015380L publication Critical patent/NO20015380L/en
Publication of NO320912B1 publication Critical patent/NO320912B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20015380A 1999-05-04 2001-11-02 Thiooxindole derivatives, pharmaceutical compositions comprising these and their use in the manufacture of medicaments. NO320912B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17225999P 1999-05-04 1999-05-04
US09/552,033 US6355648B1 (en) 1999-05-04 2000-04-19 Thio-oxindole derivatives
PCT/US2000/011630 WO2000066555A1 (en) 1999-05-04 2000-05-01 Thio-oxindole derivatives

Publications (3)

Publication Number Publication Date
NO20015380D0 true NO20015380D0 (en) 2001-11-02
NO20015380L NO20015380L (en) 2002-01-03
NO320912B1 NO320912B1 (en) 2006-02-13

Family

ID=26867898

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015380A NO320912B1 (en) 1999-05-04 2001-11-02 Thiooxindole derivatives, pharmaceutical compositions comprising these and their use in the manufacture of medicaments.

Country Status (18)

Country Link
EP (1) EP1181275A1 (en)
JP (1) JP2002543182A (en)
KR (1) KR20020000636A (en)
CN (1) CN1143847C (en)
AU (1) AU767762B2 (en)
BG (1) BG106078A (en)
BR (1) BR0010216A (en)
CA (1) CA2371633A1 (en)
CZ (1) CZ20013950A3 (en)
EA (1) EA005034B1 (en)
GE (1) GEP20043266B (en)
HU (1) HUP0200993A3 (en)
MX (1) MXPA01011285A (en)
NO (1) NO320912B1 (en)
NZ (1) NZ515351A (en)
PL (1) PL351407A1 (en)
SK (1) SK15902001A3 (en)
TR (1) TR200103288T2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1732921T3 (en) * 2004-04-08 2009-04-30 Wyeth Corp Thioamide derivatives as progesterone receptor modulators
PL1732922T3 (en) * 2004-04-08 2009-03-31 Wyeth Corp Methods for minimizing thioamide impurities
GB201113538D0 (en) * 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
EP2888268B1 (en) * 2012-10-12 2018-08-22 Okinawa Institute of Science and Technology School Corporation Novel spirooxindole derivative and process for producing the same
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
AU2017336074A1 (en) * 2016-09-30 2019-03-28 Epizyme, Inc. Substituted fused bi- or tri- heterocyclic compounds as ehmt2 inhibitors

Also Published As

Publication number Publication date
BR0010216A (en) 2002-03-19
AU767762B2 (en) 2003-11-20
JP2002543182A (en) 2002-12-17
SK15902001A3 (en) 2002-11-06
PL351407A1 (en) 2003-04-22
CA2371633A1 (en) 2000-11-09
EA200101180A1 (en) 2002-04-25
NZ515351A (en) 2004-01-30
NO320912B1 (en) 2006-02-13
CZ20013950A3 (en) 2002-06-12
EP1181275A1 (en) 2002-02-27
NO20015380L (en) 2002-01-03
CN1349499A (en) 2002-05-15
KR20020000636A (en) 2002-01-05
MXPA01011285A (en) 2003-09-04
GEP20043266B (en) 2004-06-25
HUP0200993A3 (en) 2003-05-28
AU4681400A (en) 2000-11-17
HUP0200993A2 (en) 2002-07-29
EA005034B1 (en) 2004-10-28
BG106078A (en) 2002-05-31
TR200103288T2 (en) 2002-04-22
CN1143847C (en) 2004-03-31

Similar Documents

Publication Publication Date Title
NO20000885L (en) 4-Phenyl-pyridine derivatives
NO20021077D0 (en) Amino-triazolopyridin derivatives
DE60009747D1 (en) ADMANTAN DERIVATIVES
DE50010060D1 (en) THIAZOLYLAMID DERIVATIVES
IS6128A (en) 13-Methyl-erythromycin derivatives
DK1187814T3 (en) 5-phenyl-pyrimidine derivatives
DE50013404D1 (en) SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES
NO20021803L (en) Isoksazolkarboksamid derivatives
ATE270270T1 (en) NOVEL PHENYLALKYLOXY-PHENYL DERIVATIVES
ATE257148T1 (en) PROPARGYLETHER DERIVATIVES
ATE273272T1 (en) MEVINOLINE DERIVATIVES
ATE374747T1 (en) MONOFLUORALKYL DERIVATIVES
DK1187815T3 (en) 4-phenyl-pyrimidine derivatives
ATE254598T1 (en) 4-HYDROXYBIPHENYLHYDRAZIDE DERIVATIVES
ATE293592T1 (en) RESOCINE DERIVATIVES
TR200002831A3 (en) Quinolin-4-Il derivatives I
DE60025348D1 (en) Ethanesulfonyl-PIPERIDINE DERIVATIVES
NO20020212L (en) 3-amino-2-benzyl-1-phenylpropane derivatives
NO20022867D0 (en) Syklopentenon derivatives
DK1178984T3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives
NO20022927D0 (en) Substituted pyrrazoles
NO20015380D0 (en) Tio-oxindole derivative
DE59909774D1 (en) 1-CYCLOALKYLPYRAZOLYL-BENZOYL DERIVATIVES
DE50003921D1 (en) SUBSTITUTED PHENYLURACILE
ID30507A (en) DIARILAMINA SUBSTITUTED 1-HETEROSICLUS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application